Nitric Oxide Consumption as a Predictor of Vasospasm in Subarachnoid Hemorrhage (NCT07614906)
Nitric Oxide Consumption as a Predictor of Vasospasm in Subarachnoid Hemorrhage (SAH): a Prospective Observational Study
🩺 Plain-English Summary (8th-Grade Level)
The goal of this observational study is to understand if angiographic cerebral vasospasm (CV) can be predicted by levels of nitric oxide (NO) consumption in patients with aneurysmal subarachnoid hemorrhage (SAH). To reach this goal, the investigators will compare NO consumption levels in SAH and non-SAH patients. NO consumption levels will be analyzed from samples of participants' cerebral spinal fluid (CSF).
Who can join: Review the eligibility criteria below.
Location: Massachusetts General Hospital — Boston, Massachusetts
Age range: 18 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Massachusetts General Hospital — Boston, Massachusetts
- Fondazione Policlinico Universitario Agostino Gemelli — Rome,
📞 Contact the Study Coordinator
Phone: (617) 726-3030
Email: lberra@mgh.harvard.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Aneurysmal Subarachnoid Hemorrhage
- Induced Suppression of Platelet Activity in Aneurysmal Subarachnoid Hemorrhage Management-2 (iSPASM-2) — Durham, North Carolina
- Deferoxamine In the Treatment of Aneurysmal Subarachnoid Hemorrhage (aSAH) — Ann Arbor, Michigan
- The Effect of Transcutaneous Vagal Nerve Stimulation (tVNS) on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid Hemorrhage — Birmingham, Alabama
- Dome-Only Aneurysm Coiling in Severe Aneurysmal Subarachnoid Hemorrhage — Louisville, Kentucky
- Tocilizumab-aazg for Hemorrhage: Reduction of Ischemic Vascular Events — Gainesville, Florida
Explore by condition: All Aneurysmal Subarachnoid Hemorrhage clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.